Trial Profile
Safety, Tolerability and Pharmacokinetics Studies Following Multiple Subcutaneous Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Vunakizumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Jiangsu Hengrui Medicine Co.
- 25 Oct 2018 New trial record